Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Enbumyst (bumetanide) Nasal Spray for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease

(BUSINESS WIRE) September 15, 2025 --Corstasis Therapeutics Inc., an innovative biopharmaceutical company providing enhanced outpatient therapeutic options...

Intercept Announces Voluntary Withdrawal of Ocaliva for Primary Biliary Cholangitis (PBC) from the US Market; FDA Places US Clinical Trials on Hold

September 12, 2025. MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary...

FDA Approves Selumetinib for Pediatric Patients 1 year of Age and Older with Neurofibromatosis Type 1 with Symptomatic, Inoperable Plexiform Neurofibromas

On September 10, 2025, the Food and Drug Administration approved selumetinib (Koselugo, AstraZeneca Pharmaceuticals LP) granules and capsules for pediatric...

OpenAI Launches Teen-Safe ChatGPT With Parental Controls

THURSDAY, Sept. 18, 2025 — Teenagers chatting with ChatGPT will soon see a very different version of the tool — one built with stricter ways to keep...

Boar’s Head Faces Pressure From Congress Over Plans to Reopen After Listeria Deaths

THURSDAY, Sept. 18, 2025 — Federal officials are raising concerns about whether a Virginia Boar’s Head deli meat plant, linked to last year’s deadly...

Experimental Patch Provides Real-Time Feedback On Muscle Performance

THURSDAY, Sept. 18, 2025 — An experimental wireless patch might help injured athletes better recover from muscle tears, sprains and strains, according...

Bladder Control Problems? There May Be An App For That

THURSDAY, Sept. 18, 2025 — Having trouble with bladder control? There might be an app for that, researchers say.Female veterans suffering from urinary...

Alcohol-Induced Deaths Almost Doubled From 1999 to 2024

Rates of alcohol-induced deaths among U.S. adults nearly doubled from 1999 to 2024, according to a study published online Sept. 17 in PLOS Global...

Digital Intervention Aids Psychological Outcomes With Inflammatory Rheumatic Diseases

A digital psychological intervention is safe and effective for individuals with inflammatory rheumatic diseases (IRDs), according to a study published...

Long COVID Linked to Abnormal Uterine Bleeding

Long COVID is associated with abnormal uterine bleeding (AUB), but not with impaired ovarian function, according to a study published online Sept. 16 in...

GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity

Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with knee...

On World Sepsis Day, Doctors Urge Americans to Know the Signs

SATURDAY, Sept. 13, 2025 — On World Sepsis Day, health experts remind Americans that sepsis strikes 1.7 million people in the U.S. each year and...

Read more news...

Recently Added

Recently added consumer and prescribing information: Enbumyst, Inlexzo, Nuvaxovid, mNEXSPIKE, Cyklx, Papzimeos, Brinsupri, Zegfrovy, Lynozyfic, Arynta

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Enbumyst Enbumyst (bumetanide) nasal spray is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic...
  • Ocaliva Ocaliva (obeticholic acid) is a first-in-class farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis.
  • Inlexzo Inlexzo (gemcitabine intravesical system) is a treatment for certain patients with BCG-unresponsive non-muscle invasive bladder cancer

More FDA approvals